DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 01 · Volume 53 · February 2020 DOI: 10.1055/s-010-45471

Original Paper

5
Zheng, Wei; Li, Xian-Bin; Shi, Zhan-Ming; Yang, Xin-Hu; Cai, Dong-Bin; Ng, Chee H.; Ungvari, Gabor S.; Liu, Wei-Jian; Wu, Yu-Jie; Wang, Yuan-Yuan; Ning, Yu-Ping; Xiang, Yu-Tao: Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials
Supplementary Material
21
Schaefer, Martin; Sarkar, Susanne; Theophil, Ines; Leopold, Karolina; Heinz, Andreas; Gallinat, Jürgen: Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia
Supporting Information
30
Scherf-Clavel, Maike; Weidner, Anne; Deckert, Jürgen; Menke, Andreas; Unterecker, Stefan: Pathological Concentration of C-reactive Protein is Correlated to Increased Concentrations of Quetiapine, But Not of Risperidone, Olanzapine and Aripiprazole in a Naturalistic Setting

Review

14
Schönfeldt-Lecuona, Carlos; Cronemeyer, Maximilian; Hiesener, Lilli; Connemann, Bernhard J.; Gahr, Maximilian; Sartorius, Alexander; Mühlbauer, Viktoria: Comparison of International Therapy Guidelines with Regard to the Treatment of Malignant Catatonia

Letter to the Editor

37
Scherbaum, Norbert; Holzbach, Rüdiger; Stammen, Gunnar; Kirchof, Ute; Bonnet, Udo: Very Low Frequency of Drug Therapy of Alcohol Dependence in Germany – Analysis of Data of A Statutory Health Insurance